CIK 0001437402
- Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- 4 Open-market sale Chief Development Officer sold 3,000 shares at $4.63 ($13,888)
- 4 Open-market sale Chief Commercial Officer sold 5,586 shares at $3.00 ($16,764)
- 4 Open-market sale Chief Medical Officer sold 3,187 shares at $3.00 ($9,564)
- 4 Open-market sale Blanks Robert sold 3,394 shares at $3.00 ($10,185)
- 4 Open-market sale GRAMMER ELIZABETH A sold 2,914 shares at $3.00 ($8,745)
- 4 Open-market sale President & CEO sold 13,449 shares at $3.00 ($40,360)
- 4 Open-market sale Felsch Robert Ora sold 3,214 shares at $3.00 ($9,645)
- 4 Open-market sale Chief Financial Officer sold 3,439 shares at $3.00 ($10,320)
- 4 Open-market sale Chief Development Officer sold 4,508 shares at $3.00 ($13,529)
- 4 Grant or award Chief Development Officer acquired 103,325 shares (grant or award)
- 4 Grant or award Felsch Robert Ora acquired 26,000 shares (grant or award)
- 4 Grant or award Blanks Robert acquired 78,000 shares (grant or award)
- 4 Grant or award GRAMMER ELIZABETH A acquired 78,000 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 78,000 shares (grant or award)
- 4 Grant or award Chief Commercial Officer acquired 78,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 78,000 shares (grant or award)
- 4 Grant or award President & CEO acquired 250,000 shares (grant or award)
- 4 Open-market sale Chief Development Officer sold 1,948 shares at an average $1.95 ($3,797)
- 4 Open-market sale GRAMMER ELIZABETH A sold 1,242 shares at an average $1.95 ($2,421)
- 4 Open-market sale Chief Commercial Officer sold 3,456 shares at an average $1.95 ($6,736)
Page 13 of 35 · 696 filings